Navigation Links
Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
Date:5/13/2009

OXFORD, England, May 13 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has initiated a phase II clinical development programme for its ragweed allergy therapy. The treatment for allergic rhino-conjunctivitis caused by ragweed pollen is based on Circassia's ToleroMune(R) technology, which has previously achieved successful phase II results in patients with cat allergies. Ragweed is one of the leading causes of allergic reactions in North America, where allergies to its pollen are commonly referred to as 'hay fever'. Circassia is undertaking its latest phase II clinical study in Canada. The double-blind, randomised trial will include 50 patients with confirmed ragweed allergies, and will compare a range of ToleroMune doses with placebo. Unlike most current immunotherapies, which require careful dose escalation over many months and several years of maintenance doses, patients will receive just four standardized doses of ToleroMune treatment over a number of weeks. During the trial investigators will 'challenge' the volunteers with ragweed pollen to assess the impact of the therapy. "Broadening the range of allergies targeted by ToleroMune is an important step for Circassia, underlining our confidence in this breakthrough technology. We have already achieved encouraging results in patients with cat allergies, and are excited to be extending our portfolio of therapies to encompass ragweed allergy," said Steve Harris, Circassia's CEO. "Allergies to ragweed pollen are very common in the US, where they affect over a quarter of the population, and are a growing problem in Europe. We believe that Circassia's new therapy should offer patients important benefits, as ToleroMune has the potential to address the underlying cause of allergy using short, simple courses of treatment that minimize the risk of severe and sometimes life-threatening side effects associated with many exi
'/>"/>

SOURCE Circassia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
2. Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
3. Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology
4. Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
5. Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development
6. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
7. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
8. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
9. AFFiRiS Begins Development of a Parkinsons Vaccine
10. Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
11. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014  AVT, Inc. (OTC ... automated retailing, micro-stores, custom vending machines and kiosks, ... automated medicine dispensing systems, which can be used ... and marijuana dispensaries. AVT,s newly designed systems provide ... medicines and regulated products. "We are ...
(Date:7/21/2014)... July 21, 2014   Aventura , the leader ... announced today that MemorialCare Health System , ... computing solution at the Orange Coast Memorial ... Orange Coast Memorial is a 218-bed ... 12,000 patients annually. The Aventura Roaming Aware Desktop ...
(Date:7/21/2014)... July 21, 2014   Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines ... & Drug Administration (FDA) has granted orphan drug ... oligonucleotide that binds to and inhibits the function ... treatment of Alport syndrome, a life-threatening genetic kidney ...
Breaking Medicine Technology:Technology Driving Cannabis Industry 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 2MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 3MemorialCare Health System Launches Aventura at Orange Coast Memorial Medical Center 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5
... Recession-driven budget cuts by hospitals and governmental entities reduced sales ... throughout fiscal 2010.  The company managed to offset much of ...  Still, the company reported a loss for the year. ... Allied sales fell about $6 million, or more than 11.7 ...
... ATLANTA and NEW YORK, Aug. 30 Inc. ... 2230 on its fourth annual Inc. 5000 list, an ... list represents the most comprehensive look at the most ... Music website Pandora, convenience store chain 7-Eleven, Brooklyn Brewery, ...
Cached Medicine Technology:Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 2Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 3Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 4Recession Leads to Sales Decline and Loss for Allied Healthcare Products in Fiscal 2010 5West Physics Consulting Lands on the 2010 Inc. 5000 List 2West Physics Consulting Lands on the 2010 Inc. 5000 List 3
(Date:7/22/2014)... 22, 2014 For the past nine ... have been working in tandem to help thousands of ... access to care, and help survivors connect to resources ... foundations expanded their partnership to include referrals from PAF ... with the other practical, emotional, and financial issues that ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Get ... the Immune Deficiency Foundation (IDF) to provide ... portal that will allow them to electronically track their ... manage their illnesses. It will also allow those patients ... to consent to have their data shared with ...
(Date:7/22/2014)... Atreo Services will be presenting its full range ... accessories in booth #1423 at the American Society for ... Chicago, Ill., Aug. 3-6. , Atreo will display its ... well as its selection of liners and inserts designed ... In addition, representatives will be available to talk about ...
(Date:7/22/2014)... 2014 Altec Products, Inc. , ... announced today their Gold Sponsorship of Sage Summit ... Bay Hotel and Casino in Las Vegas, Nevada. The ... thousands interested in taking advantage of the many opportunities ... business problems and educate themselves on the latest enterprise ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Dr. ... to announce the launch of a new website dedicated ... The website can be found at DrKamrava.com . ... provide patients with a knowledgeable and trustworthy source for ... they suffer from hemorrhoids, fissures, gallstones, colon cancer, hernias, ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Atreo Services to Introduce Pneumatic Tube System Solutions at ASHE Annual Conference 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 2Health News:Los Angeles Doctor Launches Brand New Website for Colorectal Surgery and Treatment 3
... Texas, M. D. Anderson Cancer Center, John Mendelsohn, has been ... . This announcement was made in Paris, for his path ... Foundation which is located at the Tel Aviv University distributed ... million each to laureates chosen in areas where the contribution ...
... be the reason why isolated women are less vulnerable to falling ... ,The study is an eye-opener to the upcoming proof ... holds a clue to the reason why socially isolated men are ... studies have shown a connection between stress and immune function. But ...
... fall flat on its face, unless the government takes a leading ... local level work is going on in good measure, governments need ... area. The public Health Minister, Caroline Flint has confirmed the measures ... has sent the NHS expenditure sky rocketing almost ?1bn a year ...
... School of Public Health are one of the 14 ... Environmental Health Sciences// (NIEHS) to study the association between ... is a new study to control the rising obesity ... an individual’s body size. Working with various city departments, ...
... by Thomas Arcury, Ph.D., lead researcher, from Wake Forest University ... Carolina// widely use folk or home remedies, such as taking ... use is largely limited to home remedies, vitamins and minerals. ... more about what complementary and alternative medicine (CAM) therapies older ...
... to allegations that a perceived problem with the computer system ... schedule of thousands of babies and young children. ... initiative by the Government, to track the immunization schedule of ... that nearly 3,000 children would find themselves in the throes ...
Cached Medicine News:Health News:Women Portray Stronger Immune Response As Compared to Men, Study Suggests 2Health News:Inclination of North Carolina’s Elderly Population towards Home Remedie 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: